Cell and Gene Therapy Access Model

**Semantic type:** Governmental or Regulatory Activity

**Definition:** A program of the Centers for Medicare and Medicaid Services that aims to improve the lives of people with Medicaid living with rare and severe diseases by increasing access to potentially transformative cell and gene therapy treatments, with an initial focus on access to gene therapy treatments for people living with sickle cell disease.

**Synonyms:** - CGT Access Model - CMS Cell and Gene Therapy Access Model - CMS Sickle Cell Disease (SCD) Cell and Gene Therapy (CGT) Access Model - Cell and Gene Therapy (CGT) Access Model - Centers for Medicare and Medicaid Services Cell and Gene Therapy Access Model